1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 30508156 | REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients. | 2019 Feb 1 | 1 |